Kardiotorakalna i vaskularna hirurgija
Preoperativno lečenje anemije i optimizacija mase crvenih krvnih zrnaca
Ferric carboxymaltose in patients with heart failure and iron deficiency. (otvara novi prozor)
Izvor: N Engl J Med 2009;361(25):2436-48.
Indeks: PubMed 19920054
DOI: 10.1056/NEJMoa0908355
https://www.ncbi.nlm.nih.gov/pubmed/19920054 (otvara novi prozor)
Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's Witness. (otvara novi prozor)
Izvor: Vasc Endovascular Surg 2007;41(5):460-2.
Indeks: PubMed 17942864
DOI: 10.1177/1538574407303172
https://www.ncbi.nlm.nih.gov/pubmed/17942864 (otvara novi prozor)
Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. (otvara novi prozor)
Izvor: Catheter Cardiovasc Interv 2014;83(6):E221-6.
Indeks: PubMed 24402965
DOI: 10.1002/ccd.25389
https://www.ncbi.nlm.nih.gov/pubmed/24402965 (otvara novi prozor)
Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. (otvara novi prozor)
Izvor: Anesth Analg 2019;128(5):981-92.
Indeks: PubMed 30649068
DOI: 10.1213/ANE.0000000000004005
https://www.ncbi.nlm.nih.gov/pubmed/30649068 (otvara novi prozor)
Epoetin dosing for blood conservation in Jehovah's Witness patients undergoing cardiac surgery—a systematic review. (otvara novi prozor)
Izvor: Can J Cardiol 2014;30(Suppl):S234.
DOI: 10.1016/j.cjca.2014.07.398
http://www.onlinecjc.ca/article/S0828-282X(14)00876-9/abstract (otvara novi prozor)
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. (otvara novi prozor)
Izvor: Am J Cardiol 2012;110(7):1021-6.
Indeks: PubMed 22771376
DOI: 10.1016/j.amjcard.2012.05.036
https://www.ncbi.nlm.nih.gov/pubmed/22771376 (otvara novi prozor)
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. (otvara novi prozor)
Izvor: Eur J Heart Fail 2013;15(11):1267-76.
Indeks: PubMed 23787722
DOI: 10.1093/eurjhf/hft099
https://www.ncbi.nlm.nih.gov/pubmed/23787722 (otvara novi prozor)
Current status of pharmacologic therapies in patient blood management. (otvara novi prozor)
Izvor: Anesth Analg 2013;116(1):15-34.
Indeks: PubMed 23223098
DOI: 10.1213/ANE.0b013e318273f4ae
https://www.ncbi.nlm.nih.gov/pubmed/23223098 (otvara novi prozor)
Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. (otvara novi prozor)
Izvor: J Cardiothorac Vasc Anesth 2016;30(2):363-72.
Indeks: PubMed 26809765
DOI: 10.1053/j.jvca.2015.10.021
https://www.ncbi.nlm.nih.gov/pubmed/26809765 (otvara novi prozor)
The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. (otvara novi prozor)
Izvor: Transfusion 2008;48(4):666-72.
Indeks: PubMed 18194382
DOI: 10.1111/j.1537-2995.2007.01590.x
https://www.ncbi.nlm.nih.gov/pubmed/18194382 (otvara novi prozor)
Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). (otvara novi prozor)
Izvor: Br J Anaesth. 2022;128(5):796-805.
Indeks: PubMed 35256150
DOI: 10.1016/j.bja.2022.01.034
https://pubmed.ncbi.nlm.nih.gov/35256150/ (otvara novi prozor)
Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. (otvara novi prozor)
Izvor: Transfus Med Rev 2013;27(4):221-34.
Indeks: PubMed 24135037
DOI: 10.1016/j.tmrv.2013.09.001
https://www.ncbi.nlm.nih.gov/pubmed/24135037 (otvara novi prozor)
The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? (otvara novi prozor)
Izvor: J Thorac Cardiovasc Surg 2013;146(6):1480-7.e6.
Indeks: PubMed 23998782
DOI: 10.1016/j.jtcvs.2013.06.033
https://www.ncbi.nlm.nih.gov/pubmed/23998782 (otvara novi prozor)
Jehovah's Witnesses and cardiac surgery: a single institution's experience. (otvara novi prozor)
Izvor: Transfusion 2014;54(10 Pt 2):2745-52.
Indeks: PubMed 24809815
DOI: 10.1111/trf.12696
https://www.ncbi.nlm.nih.gov/pubmed/24809815 (otvara novi prozor)
Determining optimal treatment to correct preoperative anemia and reduce perioperative allogeneic blood transfusions in cardiac surgery: a retrospective cohort study. (otvara novi prozor)
Izvor: J Cardiothorac Vasc Anesth 2021;35(9):2631-9.
Indeks: PubMed 33483268
DOI: 10.1053/j.jvca.2020.12.044
https://pubmed.ncbi.nlm.nih.gov/33483268/ (otvara novi prozor)
Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (otvara novi prozor)
Izvor: Surg Infect (Larchmt) 2009;10(1):9-19.
Indeks: PubMed 19245362
DOI: 10.1089/sur.2008.043
https://www.ncbi.nlm.nih.gov/pubmed/19245362 (otvara novi prozor)
Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. (otvara novi prozor)
Izvor: Anaesthesia 2020;75(8):1039-49.
Indeks: PubMed 32342498
DOI: 10.1111/anae.15062
https://www.ncbi.nlm.nih.gov/pubmed/32342498 (otvara novi prozor)
Penny-wise and pound-foolish: the challenges of preoperative anaemia management. (otvara novi prozor)
Izvor: Br J Anaesth 2023;131(2):214-21.
Indeks: PubMed 37244835
DOI: 10.1016/j.bja.2023.04.038
https://pubmed.ncbi.nlm.nih.gov/37244835/ (otvara novi prozor)
Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. (otvara novi prozor)
Izvor: J Vasc Surg 2003;37(2):453-5.
Indeks: PubMed 12563221
DOI: 10.1067/mva.2003.73
https://www.ncbi.nlm.nih.gov/pubmed/12563221 (otvara novi prozor)
Intravenous iron in heart failure: beyond targeting anemia. (otvara novi prozor)
Izvor: Curr Heart Fail Rep 2011;8(1):14-21.
Indeks: PubMed 21057903
DOI: 10.1007/s11897-010-0034-4
https://www.ncbi.nlm.nih.gov/pubmed/21057903 (otvara novi prozor)
Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. (otvara novi prozor)
Izvor: J Thorac Cardiovasc Surg 2015;150(4):976-83.e1-3.
Indeks: PubMed 26211405
DOI: 10.1016/j.jtcvs.2015.06.059
https://www.ncbi.nlm.nih.gov/pubmed/26211405 (otvara novi prozor)
Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. (otvara novi prozor)
Izvor: J Nephrol 2008;21(2):236-42.
Indeks: PubMed 18446719
https://www.ncbi.nlm.nih.gov/pubmed/18446719 (otvara novi prozor)
Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. (otvara novi prozor)
Izvor: J Thorac Cardiovasc Surg 2010;139(3):621-7.
Indeks: PubMed 20042202
DOI: 10.1016/j.jtcvs.2009.10.012
https://www.ncbi.nlm.nih.gov/pubmed/20042202 (otvara novi prozor)
A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. (otvara novi prozor)
Izvor: Transfusion 2015;55(7):1644-54.
Indeks: PubMed 25702777
DOI: 10.1111/trf.13027
https://www.ncbi.nlm.nih.gov/pubmed/25702777 (otvara novi prozor)
Blood conservation strategies can be applied safely to high-risk complex aortic surgery. (otvara novi prozor)
Izvor: J Cardiothorac Vasc Anesth 2015;29(3):703-9.
Indeks: PubMed 25847415
DOI: 10.1053/j.jvca.2014.10.022
https://www.ncbi.nlm.nih.gov/pubmed/25847415 (otvara novi prozor)
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. (otvara novi prozor)
Izvor: Anesthesiology 2011;115(5):929-37.
Indeks: PubMed 22027622
DOI: 10.1097/ALN.0b013e318232004b
https://www.ncbi.nlm.nih.gov/pubmed/22027622 (otvara novi prozor)